16,656 Shares in Wright Medical Group NV (WMGI) Purchased by Fox Run Management L.L.C.

Fox Run Management L.L.C. purchased a new position in shares of Wright Medical Group NV (NASDAQ:WMGI) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 16,656 shares of the medical device company’s stock, valued at approximately $483,000.

A number of other large investors have also recently added to or reduced their stakes in the business. Amalgamated Bank lifted its stake in Wright Medical Group by 14.9% during the second quarter. Amalgamated Bank now owns 16,232 shares of the medical device company’s stock worth $421,000 after purchasing an additional 2,102 shares in the last quarter. OppenheimerFunds Inc. raised its stake in shares of Wright Medical Group by 0.5% in the first quarter. OppenheimerFunds Inc. now owns 645,664 shares of the medical device company’s stock valued at $12,810,000 after acquiring an additional 2,936 shares in the last quarter. Rhumbline Advisers raised its stake in shares of Wright Medical Group by 4.5% in the second quarter. Rhumbline Advisers now owns 99,783 shares of the medical device company’s stock valued at $2,590,000 after acquiring an additional 4,294 shares in the last quarter. Strs Ohio raised its stake in shares of Wright Medical Group by 850.0% in the second quarter. Strs Ohio now owns 5,700 shares of the medical device company’s stock valued at $147,000 after acquiring an additional 5,100 shares in the last quarter. Finally, Principal Financial Group Inc. raised its stake in shares of Wright Medical Group by 7.0% in the first quarter. Principal Financial Group Inc. now owns 92,781 shares of the medical device company’s stock valued at $1,841,000 after acquiring an additional 6,084 shares in the last quarter.

WMGI has been the topic of several analyst reports. Guggenheim upgraded Wright Medical Group from a “neutral” rating to a “buy” rating in a research note on Wednesday, June 13th. TheStreet upgraded Wright Medical Group from a “d+” rating to a “c-” rating in a research note on Wednesday, June 13th. Leerink Swann increased their price objective on Wright Medical Group from $27.00 to $32.00 and gave the company an “outperform” rating in a research note on Thursday, June 21st. BMO Capital Markets reiterated a “market perform” rating and issued a $25.00 price objective on shares of Wright Medical Group in a research note on Tuesday, July 10th. They noted that the move was a valuation call. Finally, Cantor Fitzgerald increased their price objective on Wright Medical Group from $30.00 to $35.00 and gave the company an “overweight” rating in a research note on Thursday, August 9th. Two analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $31.08.

NASDAQ:WMGI opened at $27.82 on Tuesday. The firm has a market capitalization of $3.10 billion, a P/E ratio of -126.45 and a beta of 1.12. The company has a debt-to-equity ratio of 1.87, a quick ratio of 1.57 and a current ratio of 2.06. Wright Medical Group NV has a 12 month low of $19.01 and a 12 month high of $29.50.

Wright Medical Group (NASDAQ:WMGI) last posted its earnings results on Wednesday, August 8th. The medical device company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.06) by $0.03. The firm had revenue of $205.40 million for the quarter, compared to analyst estimates of $197.20 million. Wright Medical Group had a negative return on equity of 1.94% and a negative net margin of 24.74%. Wright Medical Group’s revenue for the quarter was up 14.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.07) earnings per share. Analysts predict that Wright Medical Group NV will post -0.15 EPS for the current fiscal year.

In related news, SVP Jennifer S. Walker sold 11,466 shares of the stock in a transaction on Thursday, August 9th. The stock was sold at an average price of $28.60, for a total value of $327,927.60. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Lance A. Berry sold 1,182 shares of the stock in a transaction on Thursday, August 16th. The shares were sold at an average price of $27.19, for a total value of $32,138.58. The disclosure for this sale can be found here. Insiders sold 14,405 shares of company stock worth $407,783 in the last three months. 4.00% of the stock is currently owned by corporate insiders.

About Wright Medical Group

Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells extremities and biologics products. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth.

See Also: Buyback

Want to see what other hedge funds are holding WMGI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Wright Medical Group NV (NASDAQ:WMGI).

Institutional Ownership by Quarter for Wright Medical Group (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply